Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Technology appraisal guidance [TA352]
MARKET TRENDS IN GLP-1 USAGE Recent market data suggest that around 5% of US adults (approximately 12.5 million people) have used or are currently using GLP-1s for weight loss alone.3 This is higher than the 7.4 million4 people (both adults and children) using insulin and equal to the 5% who have used or are currently using GLP-1s solely to treat a chronic condition such as diabetes or heart disease approximately 3% are using GLP-1s to both treat a chronic condition and to lose weight
Cell Mol Life Sci 60:350377
Side effects are mild to moderate and bioavailability is high in mice but excellent under skin
US$ 25.44
US$ 24.06
US$ 24.90
